(Q57214411)

English

Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients

No description defined

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

I G Hwang

1

0 references

J S Jang

2

0 references

J H Do

3

0 references

J H Kang

4

0 references

G W Lee

5

0 references

S Y Oh

6

0 references

H C Kwon

7

0 references

H J Jun

8

0 references

H Y Lim

9

0 references

S Lee

10

0 references

K C Chi

11

0 references

S J Lee

12

0 references

language of work or name

0 references

publication date

October 2011

0 references

Cancer Chemotherapy and Pharmacology

0 references

68

0 references

4

0 references

935-44

0 references

Psoriasin (S100A7) expression and invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

In vitro studies on the mechanisms of oxaliplatin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Systemic therapy for biliary tract cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Platinum resistance: the role of DNA repair pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1558-3

21 January 2018

Identifiers

10.1007/S00280-011-1558-3

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57214411&oldid=2213358796"